Mingyue Xu

2PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 14, 2024
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy.

Mingyue Xu, Yifeng Wang, Meihe Wu

Pageof 1